Literature DB >> 18946603

Prometheus' spirit: quality survival in advanced hepatocellular carcinoma after gemcitabine and cisplatin-based chemotherapy.

D C Doval1, S B Pande, J B Sharma, K Pavithran, A Jena, A K Vaid.   

Abstract

In advanced virus-induced hepatocellular carcinoma (HCC) associated with cirrhosis, the average survival is four months. We report a 56-year-old man with a large-volume advanced HCC, in whom gemcitabine and cisplatin-based chemotherapy resulted in near-complete regression, and quality survival of 24 months.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18946603

Source DB:  PubMed          Journal:  Singapore Med J        ISSN： 0037-5675            Impact factor:   1.858


  2 in total

1.  High-frequency ultrasound imaging for longitudinal evaluation of non-alcoholic fatty liver disease progression in mice.

Authors:  Itziar Fernández-Domínguez; J Javier Echevarria-Uraga; Nieves Gómez; Zigmund Luka; Conrad Wagner; Shelly C Lu; José M Mato; Maria L Martínez-Chantar; Juan Rodríguez-Cuesta
Journal:  Ultrasound Med Biol       Date:  2011-06-08       Impact factor: 2.998

2.  Gemcitabine and cisplatin-based combination chemotherapy in advanced hepatocellular carcinoma: An Indian experience.

Authors:  Shripad B Pande; D C Doval; K Pavithran; J B Sharma; Rashmi Shirali; A Jena
Journal:  Indian J Med Paediatr Oncol       Date:  2012-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.